Reaction
Cerebral Nocardiosis reporting signals
As of the last recalculation, Cerebral Nocardiosis appears in 211 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR HYDROCHLORIDE POWDER, (PRR 386.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Valganciclovir Hydrochloride Powder, | 39 | 386.7 | 388.0 |
| Valganciclovir | 41 | 266.0 | 266.6 |
| Valganciclovir Hydrochloride | 41 | 266.0 | 266.6 |
| Mycophenilic Acid | 37 | 213.4 | 213.7 |
| Tacrolimus Ointment 0.1% | 116 | 202.9 | 203.1 |
| Tacrolimus Extended-Release Capsules | 116 | 202.3 | 202.5 |
| Tacrolimus | 121 | 177.3 | 177.5 |
| Mycophenolic Acid | 37 | 138.1 | 138.2 |
| Remdesivir | 9 | 69.5 | 69.6 |
| Meropenem | 17 | 56.7 | 56.8 |